next-generation sequencing data drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| PGC | associated_with | next-generation sequencing data | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex lipoprotein(a) KIV-2 VNTR. (2024)
- Rare variant phasing using paired tumor:normal sequence data. (2019)
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences. (2016)
- HLAreporter: a tool for HLA typing from next generation sequencing data. (2015)
- ACMG clinical laboratory standards for next-generation sequencing. (2013)
- Pathway analysis of genomic data: concepts, methods, and prospects for future development. (2012)
- The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ngs data | drug | 5 | 5 |
| next-generation sequencing data | drug | 2 | 2 |